Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1994-11-15
pubmed:abstractText
Alveolar macrophages (AM) play a regulatory role in asthma. AM from asthmatics are activated, release increased amounts of cytokines, and express higher levels of the low affinity receptor for IgE (Fc epsilon RIIb/CD23b) and receptors for adhesion molecules. The bronchial microenvironment may modulate the phenotypic and functional characteristics of AM. On AM from normal subjects, the effects of histamine were studied on the expression of adhesion molecules (LFA-1, ICAM-1) and CD23b as well as on the release of fibronectin. The expression of LFA-1, ICAM-1, and CD23b was examined by immunocytochemistry using the alkaline phosphatase-anti-alkaline phosphatase technique. The expression of CD23b mRNA was studied by in situ hybridization. The release of fibronectin was measured by enzyme immunoassay. We found that histamine induced in a dose- and time-dependent fashion a significant increase of AM expressing the three membrane markers and a significant increase in the release of fibronectin. The maximum effect of histamine was observed after an incubation of 12 to 24 h and a dose of 1 microM. The histamine effects were specific, since they were significantly inhibited by an H1-blocker, pyrilamine, used at a concentration of 10 microM. The effect of an H2-blocker (ranitidine, concentration of 10 microM) was inconstant. Cycloheximide blocked the histamine effects, suggesting that it requires protein synthesis for its action. This study provides an in vitro model of cellular interaction between mast cells and AM, which might be relevant in the airway inflammation in asthma.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1044-1549
pubmed:author
pubmed:issnType
Print
pubmed:volume
11
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
456-63
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:7917313-Adult, pubmed-meshheading:7917313-Aged, pubmed-meshheading:7917313-Asthma, pubmed-meshheading:7917313-Bronchoalveolar Lavage Fluid, pubmed-meshheading:7917313-Cells, Cultured, pubmed-meshheading:7917313-Cycloheximide, pubmed-meshheading:7917313-Dose-Response Relationship, Drug, pubmed-meshheading:7917313-Drug Interactions, pubmed-meshheading:7917313-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:7917313-Female, pubmed-meshheading:7917313-Fibronectins, pubmed-meshheading:7917313-Histamine, pubmed-meshheading:7917313-Humans, pubmed-meshheading:7917313-Immunoenzyme Techniques, pubmed-meshheading:7917313-Immunohistochemistry, pubmed-meshheading:7917313-Intercellular Adhesion Molecule-1, pubmed-meshheading:7917313-Lymphocyte Function-Associated Antigen-1, pubmed-meshheading:7917313-Macrophages, Alveolar, pubmed-meshheading:7917313-Male, pubmed-meshheading:7917313-Middle Aged, pubmed-meshheading:7917313-Phenotype, pubmed-meshheading:7917313-Pyrilamine, pubmed-meshheading:7917313-Receptors, IgE
pubmed:year
1994
pubmed:articleTitle
Phenotypic and functional modulation of normal human alveolar macrophages by histamine.
pubmed:affiliation
Clinique des Maladies Respiratoires, Hopital Arnaud de Villeneuve, Montpellier, France.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't